Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

HIV eludes body’s smart bomb

08.07.2003


HIV inactivates the body’s cellular smart bomb



HIV eludes one of the body’s key smart bomb defenses against infection, and this finding may lay the groundwork for new drugs to treat AIDS, according to a new Salk Institute study.

Nathaniel Landau, a Salk Institute associate professor, and his team have pinpointed how the body battles HIV, a tremendously complex and relentless virus. Their findings appear in the online issue of Cell and will be published in the July 11 print issue.


"What we have uncovered is a war that is being fought on the molecular level between viruses and cells. The war has been going on for millions of years, but we didn’t know about it until now," said Landau.

"We have been focusing on an antiviral system that we never knew about-a single protein called APOBEC3G. APOBEC3G would be a powerful inhibitor of viruses such as HIV, except for one problem: the virus has outsmarted it. During the evolutionary war between the virus and the host, the virus developed an effective counter-measure."

That counter-measure is a gene in HIV called virion infectivity factor (Vif). In an HIV-infected cell, according to Landau, Vif molecules are produced and then attach to the APOBEC3G protein molecules. Once attached, Vif prevents APOBEC3G from getting into the new viruses, and these viruses go on to replicate and spread throughout the body.

Having identified the interaction between Vif and APOBEC3G, Landau and his team then focused on a fundamental question: would it be possible to beat the virus at its own game?

"We found that mice also have the antiviral protein," said Landau. "But interestingly, HIV can’t recognize the mouse protein. As a result, mouse APOBEC3G is a powerful blocker of HIV replication. The mouse APOBEC3G protein goes into HIV and Vif can’t kick it out."

The mouse APOBEC3G functions like a smart bomb with a time-delayed fuse. When the virus is produced in an infected cell, APOBEC3G molecules get into the virus. At first, the protein does nothing; however, when the virus infects a new cell, APOBEC3G is activated. As HIV begins to copy its genes into DNA, APOBEC3G attacks the virus, creating massive mutations. APOBEC3G attacks the cytosines in the virus DNA, removing an essential chemical group to make them into uracil. The viral DNA is so badly mutated that the viral genes can’t function.

"Drug companies may be able to use this information to design a novel type of drug to treat HIV infection. They could develop drugs that attach to APOBEC3G, physically blocking Vif from attaching. If Vif can’t bind to APOBEC3G, the process of HIV replication could be halted," said Landau.

The lead author of the paper was Roberto Mariani, a staff scientist at the Salk Institute. Co-authors of the paper include Darlene Chen, Bärbel Schröfelbauer, Francisco Navarro, Renate König, Brooke Bollman, Carsten Münk, Henrietta and Nymark-McMahon, all of the Salk Institute. The study was funded by the National Institutes of Health, the Elizabeth Glaser Pediatric AIDS Foundation and Concerned Parents for AIDS Research.


The Salk Institute for Biological Studies, located in La Jolla, Calif., is an independent nonprofit organization dedicated to fundamental discoveries in the life sciences, the improvement of human health and conditions, and the training of future generations of researchers. Jonas Salk, M.D., founded the institute in 1960 with a gift of land from the City of San Diego and the financial support of the March of Dimes Birth Defects Foundation.

Robert Bradford | EurekAlert!
Further information:
http://www.salk.edu/

More articles from Health and Medicine:

nachricht New study points the way to therapy for rare cancer that targets the young
22.11.2017 | Rockefeller University

nachricht Penn study identifies new malaria parasites in wild bonobos
21.11.2017 | University of Pennsylvania School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Frictional Heat Powers Hydrothermal Activity on Enceladus

Computer simulation shows how the icy moon heats water in a porous rock core

Heat from the friction of rocks caused by tidal forces could be the “engine” for the hydrothermal activity on Saturn's moon Enceladus. This presupposes that...

Im Focus: Nanoparticles help with malaria diagnosis – new rapid test in development

The WHO reports an estimated 429,000 malaria deaths each year. The disease mostly affects tropical and subtropical regions and in particular the African continent. The Fraunhofer Institute for Silicate Research ISC teamed up with the Fraunhofer Institute for Molecular Biology and Applied Ecology IME and the Institute of Tropical Medicine at the University of Tübingen for a new test method to detect malaria parasites in blood. The idea of the research project “NanoFRET” is to develop a highly sensitive and reliable rapid diagnostic test so that patient treatment can begin as early as possible.

Malaria is caused by parasites transmitted by mosquito bite. The most dangerous form of malaria is malaria tropica. Left untreated, it is fatal in most cases....

Im Focus: A “cosmic snake” reveals the structure of remote galaxies

The formation of stars in distant galaxies is still largely unexplored. For the first time, astron-omers at the University of Geneva have now been able to closely observe a star system six billion light-years away. In doing so, they are confirming earlier simulations made by the University of Zurich. One special effect is made possible by the multiple reflections of images that run through the cosmos like a snake.

Today, astronomers have a pretty accurate idea of how stars were formed in the recent cosmic past. But do these laws also apply to older galaxies? For around a...

Im Focus: Visual intelligence is not the same as IQ

Just because someone is smart and well-motivated doesn't mean he or she can learn the visual skills needed to excel at tasks like matching fingerprints, interpreting medical X-rays, keeping track of aircraft on radar displays or forensic face matching.

That is the implication of a new study which shows for the first time that there is a broad range of differences in people's visual ability and that these...

Im Focus: Novel Nano-CT device creates high-resolution 3D-X-rays of tiny velvet worm legs

Computer Tomography (CT) is a standard procedure in hospitals, but so far, the technology has not been suitable for imaging extremely small objects. In PNAS, a team from the Technical University of Munich (TUM) describes a Nano-CT device that creates three-dimensional x-ray images at resolutions up to 100 nanometers. The first test application: Together with colleagues from the University of Kassel and Helmholtz-Zentrum Geesthacht the researchers analyzed the locomotory system of a velvet worm.

During a CT analysis, the object under investigation is x-rayed and a detector measures the respective amount of radiation absorbed from various angles....

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Ecology Across Borders: International conference brings together 1,500 ecologists

15.11.2017 | Event News

Road into laboratory: Users discuss biaxial fatigue-testing for car and truck wheel

15.11.2017 | Event News

#Berlin5GWeek: The right network for Industry 4.0

30.10.2017 | Event News

 
Latest News

Underwater acoustic localization of marine mammals and vehicles

23.11.2017 | Information Technology

Enhancing the quantum sensing capabilities of diamond

23.11.2017 | Physics and Astronomy

Meadows beat out shrubs when it comes to storing carbon

23.11.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>